MedPath

Randomized Controlled Trial (RCT) Umbilical Hernia Repair (UHR) Absorbable vs Non-absorbable Synthetic Mesh

Not Applicable
Withdrawn
Conditions
Umbilical Hernia
Interventions
Device: Marlex
Device: Enform Mesh
Registration Number
NCT05994248
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

The goal of this study is to see which of two types of mesh is better for fixing an umbilical hernia. One type of mesh is an absorbable synthetic mesh, which goes away on its own in the body, and the other type of mesh is a non-absorbable mesh, which stays in the body forever. The researchers will check if the hernia comes back, how it affects the patient's quality of life, and if there are any problems after the surgery during a three-year period.

Detailed Description

The goal of this study is to compare the use of absorbable synthetic (AS) mesh versus non-absorbable mesh (NAS) mesh to determine the 3-year recurrence, quality of life (QOL) and postoperative complications in umbilical hernia repair. Patients will be randomized into one of two arms to receive an absorbable (Enform) mesh or non-absorbable (Marlex) mesh. Patients will undergo an umbilical hernia repair with the mesh assigned to their randomization cohort. The hernia recurrence, quality of life and postoperative outcomes to determine if the two meshes are non-inferior.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
420
Inclusion Criteria
  • Age 18 years and older
  • Primary umbilical hernia repair (UHR) [as defined by European Hernia Society (EHS) guidelines primary midline abdominal wall defect from 3 cm above to 3 cm below the umbilicus]
  • Undergoing elective laparoscopic or open repair
  • Defect size of 1-4cm2
  • Centers for Disease Control and Prevention (CDC) class 1 & 2 wounds
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Non-Absorbable Synthetic MeshMarlexSubjects randomized to the non-absorbable synthetic mesh arm will undergo the procedure (umbilical hernia repair) to receive Marlex mesh.
Absorbable Synthetic MeshEnform MeshSubjects randomized to the absorbable synthetic mesh arm will undergo the procedure (umbilical hernia repair) to receive Enform mesh.
Primary Outcome Measures
NameTimeMethod
Umbilical Hernia Recurrence3-years postoperatively

The rate of hernia recurrence 3-years postoperatively

Secondary Outcome Measures
NameTimeMethod
Postoperative Outcomes - Length of stay3-years postoperatively

The length of stay (LOS) in the hospital postoperatively

Postoperative Outcome - 30-day readmission30-days postoperatively

The rate of 30-day readmission

Mesh Related Complication - Mesh infection1-year postoperatively

The rate of mesh infection within 1-year postoperatively

Postoperative Outcome - Seroma3-years postoperatively

The rate seroma within 3-years postoperatively

Postoperative Outcomes - Mortality3-years postoperatively

The rate of mortality within 3-years postoperatively

Mesh Related Complication - Mesh excision1-year postoperatively

The rate of mesh excision within 1-year postoperatively

Postoperative Outcome - Hematoma3-years postoperatively

The rate of hematoma within 3-years postoperatively

Postoperative Outcomes - Intra-abdominal abscess3-years postoperatively

The rate of intra-abdominal abscess within 3-years postoperatively

Postoperative Outcome - Wound cellulitis3-years postoperatively

The rate of wound cellulitis within 3-years postoperatively

Postoperative Outcome - Wound infection3-years postoperatively

The rate of wound infection within 3-years postoperatively

Quality of Life (QOL)3-years postoperatively

QOL within 3-years of surgery as measured by the Carolinas Comfort Scale (CCS), a validated hernia specific QOL questionnaire. The CCS has 23 questions across 3 domains (mesh sensation, pain, and movement) that are scored 0-5 and N/A. Higher scores indicate worse symptoms. A score of 2 or more in any category is considered "symptomatic"; a score of 0 or 1 is considered "asymptomatic". Data will be reported as the frequency and percentage of "symptomatic" or "asymptomatic" for each of the 3 domains.

Postoperative Outcome - Superficial wound breakdown3-years postoperatively

The rate of superficial wound breakdown within 3-years postoperatively

Trial Locations

Locations (1)

Carolinas Medical Center

🇺🇸

Charlotte, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath